Showing results (591-600 of 1,983) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|July 10, 2019
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Michelle Mellion, Raymond Hupperts, et al.The Lancet. Neurology|March 25, 2022
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosisStephen A Goutman, Orla Hardiman, Ammar Al-Chalabi, et al.The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.The Lancet. Neurology|February 26, 2011
Paediatric stroke: genetic insights into disease mechanisms and treatment targetsPinki Munot, Yanick J Crow, Vijeya GanesanThe Lancet. Neurology|December 21, 2010
Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trialGuy L Clifton, Alex Valadka, David Zygun, et al.The Lancet. Neurology|June 18, 2010
Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational studyHugh S Markus, Alice King, Martin Shipley, et al.The Lancet. Neurology|July 9, 2010
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challengesLeonardo PantoniThe Lancet. Neurology|June 15, 2010
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trialMads Ravnborg, Per Soelberg Sørensen, Magnus Andersson, et al.The Lancet. Neurology|August 21, 2010
Predictors and assessment of cognitive dysfunction resulting from ischaemic strokeRebecca F Gottesman, Argye E HillisPageof 199